about
2nd European Symposium on Lyme Borreliosis. A NATO advanced research workshop. United Kingdom, 19-20 May 1993. AbstractsIs Ixodes (ixodiopsis) angustus a vector of Lyme disease in Washington State?Myositis during Borrelia burgdorferi infection (Lyme disease).Detection of borreliacidal antibodies in dogs after challenge with Borrelia burgdorferi-infected ixodes scapularis ticks.Antigens of Borrelia burgdorferi recognized during Lyme disease. Appearance of a new immunoglobulin M response and expansion of the immunoglobulin G response late in the illness.DNA and protein analyses of tick-derived isolates of Borrelia burgdorferi from CaliforniaPaediatric infectious diseases: some recent advances and future priorities.An effective second-generation outer surface protein A-derived Lyme vaccine that eliminates a potentially autoreactive T cell epitopeMultiple infections of Ixodes scapularis ticks by Borrelia burgdorferi as revealed by single-strand conformation polymorphism analysis.Immunogenic integral membrane proteins of Borrelia burgdorferi are lipoproteins.Epidemiological and clinical features of 1,149 persons with Lyme disease identified by laboratory-based surveillance in Connecticut.Monoclonal antibody to native P39 protein from Borrelia burgdorferiCross-reaction with Borrelia burgdorferi antigen of sera from patients with human immunodeficiency virus infection, syphilis, and leptospirosis.Antigenic characteristics of Borrelia burgdorferi isolates from ixodid ticks in California.Characterization of Borrelia burgdorferi isolates by restriction endonuclease analysis and DNA hybridizationDogs as sentinels for human Lyme borreliosis in The Netherlands.Further characterization of a potent immunogen and the chromosomal gene encoding it in the Lyme disease agent, Borrelia burgdorferi.Immunoblot analysis of immunoglobulin G response to the Lyme disease agent (Borrelia burgdorferi) in experimentally and naturally exposed dogs.Detection of Borrelia burgdorferi using the polymerase chain reaction.Isolation and characterization of Borrelia burgdorferi from Illinois Ixodes dammini.Characterization of the inner membrane protein BB0173 from Borrelia burgdorferi.
P2860
Q27469299-8E73F1BA-307B-47D4-A660-0E6168D3C2DAQ33616913-4952C097-5150-4BEC-92E2-987A7A443044Q33628062-2DF4331F-0EB5-469C-8ADF-7764E6C5332FQ33969932-2C3EA4C0-9633-4871-A309-A0EA3691983BQ34541505-92229547-FB9E-41C3-82C7-D0AFE9A1FE99Q34550270-3999E387-DB5A-4D56-AFD3-ED6A79BA1DDEQ35625992-2C37680D-BD82-45A7-A4D9-806E8E082E09Q36017879-7F700104-B19E-4D2B-B3FC-175A9D2EF6FBQ36528502-3B545EF0-95D5-49ED-99DD-0BF1EC7ECF90Q36979610-8B5E503C-A59C-45E7-A004-33B3F0F9CC27Q36987804-E9DD8E1D-F26B-4FE8-AAE2-C2200AC782AFQ37071625-03803B26-BC7F-42B2-8CBE-C60FB2AA6880Q37160284-4557BE90-51E3-46B0-A995-24F2E0DDECA3Q37161036-01734864-3C14-4229-BC2D-BA0C09E6FB64Q37170797-72FD3EC3-CF04-4FEB-BA13-88C9A9FA2747Q39463602-4FF0B49C-9484-4D4D-A49C-A2139A23932EQ40150822-AB577534-4E66-4ADB-95E1-90A3F0805778Q40192473-50F9EBB0-6581-4F05-85D3-5F1ECFA4B3DCQ40201389-FA25498F-613E-4BCB-A1CF-F59C780E358DQ40213236-71B4E2D2-30E7-4630-B3BC-7B392F425380Q46255886-DA9FB8F2-F67A-4EFA-8BE3-42FBB3BC73E7
P2860
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
1984年论文
@zh
1984年论文
@zh-cn
name
The clinical spectrum and treatment of Lyme disease.
@en
type
label
The clinical spectrum and treatment of Lyme disease.
@en
prefLabel
The clinical spectrum and treatment of Lyme disease.
@en
P2093
P2860
P1476
The clinical spectrum and treatment of Lyme disease.
@en
P2093
A C Steere
D R Snydman
G J Hutchinson
J H Newman
N H Bartenhagen
P N Spieler
S E Malawista
P2860
P304
P577
1984-07-01T00:00:00Z